Company type | Private Limited |
---|---|
Industry | Pharmaceutical Industry |
Founded | 1990 |
Founder | Latifur Rahman |
Headquarters | Plot: 82, Road: 14 Block - B, Banani, , Bangladesh |
Key people | Simeen Rahman (Managing Director & CEO) |
Revenue | US$300 million |
Parent | Transcom Group |
Website |
skfbd |
Eskayef Pharmaceuticals Ltd., also known as SK+F, is a pharmaceutical company in Bangladesh. It belongs to the Transcom Group. [1] [2] Simeen Rahman is the Managing Director and CEO of the company. [2] [3]
Eskayef Bangladesh Ltd., a successor of Smith, Kline & French in Bangladesh, was acquired by Transcom in 1990. [2] According to an IMS report, the company was among the top six pharmaceutical companies operating in Bangladesh in terms of sales in 2021. [4] By 2021, it exported finished products to 65 countries. [2] The company was renamed Eskayef Pharmaceuticals Limited in January 2017. [5]
The company is engaged in the manufacture and marketing of a wide range of therapeutic drugs, bulk pellets and animal health and nutrition products [6] including the oral anti covid medication Molnupiravir [7] & Nirmatrelvir co-packaged with Ritonavir and injectable Remdesivir.
Company type | Private Limited |
---|---|
Industry | Pharmaceutical Industry |
Founded | 1990 |
Founder | Latifur Rahman |
Headquarters | Plot: 82, Road: 14 Block - B, Banani, , Bangladesh |
Key people | Simeen Rahman (Managing Director & CEO) |
Revenue | US$300 million |
Parent | Transcom Group |
Website |
skfbd |
Eskayef Pharmaceuticals Ltd., also known as SK+F, is a pharmaceutical company in Bangladesh. It belongs to the Transcom Group. [1] [2] Simeen Rahman is the Managing Director and CEO of the company. [2] [3]
Eskayef Bangladesh Ltd., a successor of Smith, Kline & French in Bangladesh, was acquired by Transcom in 1990. [2] According to an IMS report, the company was among the top six pharmaceutical companies operating in Bangladesh in terms of sales in 2021. [4] By 2021, it exported finished products to 65 countries. [2] The company was renamed Eskayef Pharmaceuticals Limited in January 2017. [5]
The company is engaged in the manufacture and marketing of a wide range of therapeutic drugs, bulk pellets and animal health and nutrition products [6] including the oral anti covid medication Molnupiravir [7] & Nirmatrelvir co-packaged with Ritonavir and injectable Remdesivir.